Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Generic drug maker fails to avoid inhaler patent lawsuit
Big Pharma
A Virginia court was unconvinced that the Hatch-Waxman Act did not apply.   14 July 2022
Teva takes long-running ‘skinny label’ suit to SCOTUS
Americas
Generics giant’s petition cites the cost of medicine and first-principles of innovation.   14 July 2022
Moderna, Pfizer face escalating COVID vaccine patent suits
Americas
New lawsuit comes months after the pair were accused of infringing lipid nanoparticle technology.   14 July 2022
Americas
A Delaware court found in favour of the AI company, which Microsoft bought for $16 billion last year.   12 July 2022
Americas
The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.   12 July 2022
Americas
A major generic pharma company has failed to undo patents related to the oral suspension Quillivant XR.   8 July 2022
Big Pharma
The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.   7 July 2022
Big Pharma
Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.   7 July 2022
Americas
Licensing partners aim to prevent the introduction of a proposed eye drop generic treatment before the expiration of four patents.   5 July 2022
Big Pharma
The ruling marks the latest development of a long-running dispute over the alleged delay of a generic version of the blockbuster painkiller.   5 July 2022